Kelly Gardner
Directeur Général chez Zephyrus Biosciences, Inc.
Profil
Kelly Gardner founded Zephyrus Biosciences, Inc. in 2013, where she is working as Chief Executive Officer from 2013.
Dr. Gardner received her graduate degree from the University of Cambridge, undergraduate degree from Yale University, and doctorate degree from the University of California, Berkeley.
Postes actifs de Kelly Gardner
| Sociétés | Poste | Début |
|---|---|---|
Zephyrus Biosciences, Inc.
 Zephyrus Biosciences, Inc. BiotechnologyHealth Technology Zephyrus Biosciences, Inc. provides tools for protein analysis at the single cell level. The firm's products include Z1 instrument, zWest Kits, and scWestern system which enables western blotting on individual cells. Its products are used to gain insights into the biology of cancer, stem cells, neurology, and human disease and development. The company was founded by Kelly Gardner, Amy E. Herr and Joshua Molho in 2013 and is headquartered in Berkeley, CA. | Directeur Général | 01/01/2013 |
Formation de Kelly Gardner
| University of California, Berkeley | Doctorate Degree |
| University of Cambridge | Graduate Degree |
| Yale University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Zephyrus Biosciences, Inc.
Zephyrus Biosciences, Inc. BiotechnologyHealth Technology Zephyrus Biosciences, Inc. provides tools for protein analysis at the single cell level. The firm's products include Z1 instrument, zWest Kits, and scWestern system which enables western blotting on individual cells. Its products are used to gain insights into the biology of cancer, stem cells, neurology, and human disease and development. The company was founded by Kelly Gardner, Amy E. Herr and Joshua Molho in 2013 and is headquartered in Berkeley, CA. | Health Technology |